13F reference period
Q2 2026
CUSIP: 81734D104
13F reference period
Q2 2026
Institutions Reporting
153
Shares (Excl. Options)
Price
$33.49
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 153 institutions filings for Q2 2026.
Security key
81734D104
13F reference period
Q2 2026
13F holders
153
13D/G owners
4
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 81734D104:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. | 14% | 0% | $43,509,137 | 6,215,591 | 0% | Third Rock Ventures V, L.P. | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. | 12% | $185,043,101 | 5,525,324 | RA Capital Management, L.P. | 12 Aug 2026 | |||
| DRIEHAUS CAPITAL MANAGEMENT LLC | 9.8% | -6.3% | $148,463,112 | -$7,597,307 | 4,433,058 | -4.9% | DRIEHAUS CAPITAL MANAGEMENT LLC | 30 Jun 2026 |
| BIOTECHNOLOGY VALUE FUND L P | 3.8% | -61% | $42,813,056 | -$66,562,509 | 1,720,782 | -61% | BVF PARTNERS L P/IL | 31 Dec 2025 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 16% | 6,995,858 | 0% | 2% | $234,291,284 |
| TRV GP V, LLC | 14% | 6,215,591 | 0% | 42% | $208,160,143 |
| Driehaus Capital Management LLC | 9.8% | 4,433,058 | +0.85% | 0.86% | $148,463,112 |
| TRV GP VI, LLC | 9.3% | 4,211,659 | 0% | 61% | $141,048,460 |
| SAMSARA BIOCAPITAL, LLC | 7% | 3,149,128 | 0% | 8.7% | $105,464,297 |
| GOLDMAN SACHS GROUP INC | 6.8% | 3,062,766 | +5.4% | 0.01% | $102,572,033 |
| BlackRock, Inc. | 4.3% | 1,932,088 | +6% | 0% | $64,705,629 |
| Siren, L.L.C. | 4.2% | 1,900,000 | -5% | 1.3% | $63,631,000 |
| Avoro Capital Advisors LLC | 3% | 1,337,500 | 0% | 0.4% | $44,792,875 |
| Jupiter Topco LLC | 2.9% | 1,307,500 | 0% | 0.02% | $43,722,800 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.7% | 1,221,673 | +2.1% | 0% | $40,913,829 |
| PRIMECAP MANAGEMENT CO/CA/ | 2.6% | 1,167,382 | +11% | 0.02% | $39,095,624 |
| First Light Asset Management, LLC | 2.1% | 963,260 | +31% | 2% | $32,259,577 |
| ADAR1 Capital Management, LLC | 2.1% | 940,747 | -14% | 1.5% | $31,505,617 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 679,163 | +5.3% | 0% | $22,750,071 |
| STATE STREET CORP | 1.4% | 652,630 | +3.4% | 0% | $21,856,579 |
| LOOMIS SAYLES & CO L P | 1.4% | 624,752 | 0.03% | $20,922,944 | |
| Casdin Capital, LLC | 1.2% | 553,268 | 0% | 0.93% | $18,528,945 |
| Catalio Capital Management, LP | 1.2% | 536,152 | +82% | 3.4% | $17,955,730 |
| ALGERT GLOBAL LLC | 0.88% | 397,487 | +1790% | 0.16% | $13,311,840 |
| Balyasny Asset Management L.P. | 0.78% | 350,442 | +48% | 0.02% | $11,736,303 |
| Longaeva Partners L.P. | 0.66% | 298,171 | +300% | 0.29% | $9,985,747 |
| Soleus Capital Management, L.P. | 0.61% | 275,000 | 0% | 0.32% | $9,209,750 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.51% | 230,184 | +18% | 0% | $7,708,862 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0.49% | 222,702 | -0.58% | 0.01% | $7,458,290 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 59,518 | $2,328,793 | +$1,565,634 | $39.13 | 18 |
| 2026 Q2 | 47,243,227 | $1,581,938,736 | +$56,571,616 | $33.49 | 153 |
| 2026 Q1 | 45,721,668 | $1,098,633,979 | -$3,060,281 | $24.03 | 124 |
| 2025 Q4 | 45,591,200 | $1,270,965,588 | +$27,717,426 | $27.88 | 123 |
| 2025 Q3 | 44,549,033 | $837,968,810 | +$6,406,374 | $18.81 | 82 |
| 2025 Q2 | 44,430,464 | $469,630,218 | -$8,199,247 | $10.57 | 89 |
| 2025 Q1 | 45,290,316 | $262,246,506 | -$67,734,233 | $5.79 | 69 |
| 2024 Q4 | 44,129,388 | $1,010,571,873 | +$770,183,886 | $22.90 | 71 |